FI69473C - Foerfarande foer framstaellning av terapeutiskt anvaendbara deivat av erytromycin - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara deivat av erytromycin Download PDF

Info

Publication number
FI69473C
FI69473C FI810042A FI810042A FI69473C FI 69473 C FI69473 C FI 69473C FI 810042 A FI810042 A FI 810042A FI 810042 A FI810042 A FI 810042A FI 69473 C FI69473 C FI 69473C
Authority
FI
Finland
Prior art keywords
group
formula
compound
erythromycin
oxime
Prior art date
Application number
FI810042A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI69473B (fi
FI810042L (fi
Inventor
D Ambrieres Solange Gouin
Andre Lutz
Jean-Claude Gasc
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9237443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI69473(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI810042L publication Critical patent/FI810042L/fi
Publication of FI69473B publication Critical patent/FI69473B/fi
Application granted granted Critical
Publication of FI69473C publication Critical patent/FI69473C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI810042A 1980-01-11 1981-01-08 Foerfarande foer framstaellning av terapeutiskt anvaendbara deivat av erytromycin FI69473C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8000566A FR2473525A1 (fr) 1980-01-11 1980-01-11 Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR8000566 1980-01-11

Publications (3)

Publication Number Publication Date
FI810042L FI810042L (fi) 1981-07-12
FI69473B FI69473B (fi) 1985-10-31
FI69473C true FI69473C (fi) 1986-02-10

Family

ID=9237443

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810042A FI69473C (fi) 1980-01-11 1981-01-08 Foerfarande foer framstaellning av terapeutiskt anvaendbara deivat av erytromycin

Country Status (25)

Country Link
US (1) US4349545A (es)
EP (1) EP0033255B1 (es)
JP (1) JPS56100799A (es)
KR (1) KR850000964B1 (es)
AU (1) AU537247B2 (es)
BG (1) BG61369B2 (es)
CA (1) CA1162535A (es)
CY (1) CY1319A (es)
DE (1) DE3165720D1 (es)
DK (1) DK157878C (es)
ES (1) ES8200702A1 (es)
FI (1) FI69473C (es)
FR (1) FR2473525A1 (es)
GR (1) GR73103B (es)
GT (1) GT198500080A (es)
HK (1) HK586A (es)
HU (1) HU187760B (es)
IE (1) IE50680B1 (es)
IL (1) IL61808A (es)
LU (1) LU88283I2 (es)
MY (1) MY8500984A (es)
NL (1) NL930097I2 (es)
OA (1) OA06719A (es)
PT (1) PT72331B (es)
ZA (1) ZA808108B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
NO860901L (no) 1985-03-12 1986-09-15 Beecham Group Plc Fremgangsmaate for fremstilling av farmasoeytisk aktive erytromycinderivater.
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DE3782994T2 (de) 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
DE69227713D1 (de) 1991-03-15 1999-01-14 Merck & Co Inc 9-Deoxo-9(Z)-hydroxyiminoerythromycin A und O-Derivate hiervon
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
ES2036472B1 (es) * 1991-10-01 1994-03-01 Prodesfarma Sa Procedimiento de obtencion de eritromicina 9-(0-((2-metoxietoxi)metil)oxima) (roxitromicina).
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
CA2189001A1 (en) * 1994-04-26 1995-11-02 Nobuhiro Narita Medicinal composition as a remedy for nonsmall cell lung cancer
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
PT102202B (pt) * 1998-09-10 2001-04-30 Hovione Sociedade Quimica S A Processo para a purificacao de roxitromicina
IN190782B (es) * 1998-09-30 2003-08-23 Max India Ltd
EP1004591B1 (en) * 1998-11-24 2003-04-09 Max India Limited Process for preparing roxithromycin and derivatives thereof
EP1254146B1 (en) * 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
PT1280535E (pt) * 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020991A2 (en) 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
AU2003271408B2 (en) * 2002-12-31 2008-07-17 Alembic Limited A process for the purification of roxithromycin
EP2056844A4 (en) 2006-08-24 2010-11-24 Wockhardt Research Center NEW MACROLIDS AND KETOLIDS WITH ANTIMICROBIAL EFFECT
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
EP3216798A3 (en) 2010-12-09 2017-10-25 Wockhardt Limited Ketolide compounds
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
US8993739B2 (en) 2011-03-22 2015-03-31 Wockhardt Ltd. Process for preparation of ketolide compounds
CN102219816A (zh) * 2011-05-12 2011-10-19 浙江国邦药业有限公司 一种罗红霉素的纯化方法
PL222631B1 (pl) 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
CN104163840A (zh) * 2013-08-30 2014-11-26 郑州后羿制药有限公司 一种罗红霉素的精制方法
FR3049861A1 (fr) 2016-04-07 2017-10-13 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3869444A (en) * 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
ES434842A1 (es) * 1975-02-19 1976-12-01 Andreu Sa Dr Procedimiento para la preparacion de esteres de la oxima deeritromicina.
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DE2515076A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue erythromycinderivate, deren salze und verfahren zu ihrer herstellung
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
AU6613181A (en) 1981-07-16
IE50680B1 (en) 1986-06-11
IE810046L (en) 1981-07-11
FR2473525A1 (fr) 1981-07-17
DE3165720D1 (en) 1984-10-04
JPS56100799A (en) 1981-08-12
FI69473B (fi) 1985-10-31
ZA808108B (en) 1982-01-27
NL930097I2 (nl) 1995-04-03
JPS6237639B2 (es) 1987-08-13
PT72331A (fr) 1981-02-01
OA06719A (fr) 1982-06-30
AU537247B2 (en) 1984-06-14
NL930097I1 (nl) 1993-10-01
FI810042L (fi) 1981-07-12
EP0033255B1 (fr) 1984-08-29
DK7881A (da) 1981-07-12
FR2473525B1 (es) 1983-04-15
EP0033255A1 (fr) 1981-08-05
HK586A (en) 1986-01-10
IL61808A0 (en) 1981-01-30
MY8500984A (en) 1985-12-31
GR73103B (es) 1984-02-02
GT198500080A (es) 1987-03-06
BG61369B2 (bg) 1997-06-30
PT72331B (fr) 1982-07-23
ES498395A0 (es) 1981-11-01
LU88283I2 (fr) 1994-09-09
ES8200702A1 (es) 1981-11-01
US4349545A (en) 1982-09-14
CY1319A (en) 1986-03-28
DK157878C (da) 1990-07-30
KR850000964B1 (ko) 1985-07-02
CA1162535A (fr) 1984-02-21
KR830005258A (ko) 1983-08-03
IL61808A (en) 1986-12-31
HU187760B (en) 1986-02-28
DK157878B (da) 1990-02-26

Similar Documents

Publication Publication Date Title
FI69473C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara deivat av erytromycin
DK172636B1 (en) 6-o-methylerythromycin a derivative
JP3130097B2 (ja) 新規なエリスロマイシン誘導体、その製造法、得られる新規な中間体及びそれらの薬剤としての使用
TW442490B (en) Tricyclic erythromycin derivatives
US5202434A (en) 8a-aza-8a-homoerythromycin lactams
EP0201166B1 (en) Erythromycin derivatives
EP0289030A2 (en) Esperamicin derivatives, a process for preparing them and pharmaceutical compositions
GB2135670A (en) C-20- and c-23-modified macrolide derivatives
EP0549040A1 (en) Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
EP0099747B1 (en) C-23-modified derivatives of 5-0-mycaminosyl tylonolide
EP0503932B1 (en) 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof
JPS6360031B2 (es)
AU616717B2 (en) Epipodophyllotoxin glucoside 4'-acylderivative
KR100529980B1 (ko) 신규 에리트로마이신 유도체, 그의 제조 방법 및 의약으로서의용도
BG106173A (bg) Халогенови производни на 9-дезоксо-9а-аза-9а-хомеритромицин а
KR850001179B1 (ko) 에리트로마이신 a의 옥심 유도체류의 제조방법
EP0507595A1 (en) 8A-aza-8A-homoerythromycin lactams
JPS62190188A (ja) セルビノマイシン系抗生物質誘導体およびその製造法
EP0508795A1 (en) 8a-aza-8a-homoerythromycin cyclic iminoethers
FI58502C (fi) Foerfarande foer framstaellning av alkyl-7-deoxi-7-(acors)-alfa-tiolinkosaminider vilka aer mellanprodukter vid framstaellning av substituerade tioanaloger av linkomycin
EP0515141A1 (en) Novel process for the preparation of 8A-aza-8A-homoerythromycin cyclic lactams
CN111662351A (zh) 新奥克梯隆型皂苷元衍生物及制备抗耐药菌药物应用
JPS61225194A (ja) 新規化合物，その製法及びそれを含む医薬組成物
CS199728B2 (en) Method of producing derivatives of 4"-sulphonyl amino oleandomycin
CZ280809B6 (cs) Deriváty 10,11,12,13-tetrahydrodesmykosinu, způsoby jejich přípravy a jejich použití v léčivech

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL

MA Patent expired

Owner name: HOECHST MARION ROUSSEL